The impact of GLP-1 receptor agonists on metabolic control and diabetic kidney disease progression

被引：0
|
作者：
Venda, Joao [1 ]
Henriques, Andreia Dos Santos [1 ]
Monsanto, Alice [1 ]
Pompermayer, Micael [1 ]
Leal, Rita [1 ]
Alves, Rui [1 ]
机构：
[1] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2926
引用
收藏
页码：I1204 / I1204
页数：1
相关论文
共 50 条
  • [31] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [32] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [33] GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease
    Liu, Jia
    Wang, Guang
    Jia, Yumei
    Xu, Yuan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (04) : 329 - 335
  • [34] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [35] Impact of GLP-1 Receptor Agonists on Alcohol-Related Liver Disease Development and Progression in Alcohol Use Disorder
    Kuo, Chia-Chih
    Li, Chun-Hsien
    Chuang, Min-Hsiang
    Huang, Po-Yu
    Kuo, Hsing-Tao
    Lai, Chih-Cheng
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [36] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
    Singh, Anmol
    Sohal, Aalam
    Batta, Akash
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48)
  • [37] GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
    Neumiller, Joshua J.
    Alicic, Radica Z.
    Tuttle, Katherine R.
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 386 - 398
  • [38] GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
    Granata, Antonio
    Maccarrone, Rosario
    Anzaldi, Massimiliano
    Leonardi, Giuseppe
    Pesce, Francesco
    Amico, Francesco
    Gesualdo, Loreto
    Corrao, Salvatore
    CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1657 - 1665
  • [39] Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney Disease
    Aminian, Ali
    Gasoyan, Hamlet
    Zajichek, Alexander
    Alavi, Mohammad Hesam
    Casacchia, Nicholas J.
    Wilson, Rickesha
    Feng, Xiaoxi
    Corcelles, Ricard
    Brethauer, Stacy A.
    Schauer, Philip R.
    Kroh, Matthew
    Rosenthal, Raul J.
    Taliercio, Jonathan J.
    Poggio, Emilio D.
    Nissen, Steven E.
    Rothberg, Michael B.
    ANNALS OF SURGERY, 2024, 280 (03) : 414 - 423
  • [40] Impact of GLP-1 Agonists on the Severity of Inflammatory Bowel Disease
    Coats, Sarah
    Anderson, Scott R.
    Ayoub, Malek
    Deepak, Parakkal
    McHenry, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1022 - S1023
12345